Provider effects in antibiotic prescribing

References

1. 1. Abaluck, J.,
   2. Agha, L.,
   3. Chan, D.,
   4. Singer, D. E., and
   5. Zhu, D.

   (2022). Fixing Misallocation with Guidelines: Awareness vs. Adherence.
2. 1. Abaluck, J.,
   2. Agha, L.,
   3. Kabrhel, C.,
   4. Raja, A., and
   5. Venkatesh, A.

   (2016). The determinants of productivity in medical testing: Intensity and allocation of care. American Economic Review, 106(12):3730–64.

   OpenUrlCrossRef
3. 1. Adda, J.

   (2020). Preventing the spread of antibiotic resistance. AEA Papers and Proceedings, 110:255–259.

   OpenUrl
4. 1. Agarwal, N.,
   2. Moehring, A.,
   3. Rajpurkar, P., and
   4. Salz, T.

   (2023). Combining Human Expertise with Artificial Intelligence: Experimental Evidence from Radiology. NBER Working Paper No. 31422.
5. 1. Agha, L.,
   2. Ericson, K. M.,
   3. Geissler, K. H., and
   4. Rebitzer, J. B.

   (2022a). Team Relationships and Performance: Evidence from Healthcare Referral Networks. Management Science, 68(5):3735–3754.

   OpenUrl
6. 1. Agha, L.,
   2. Skinner, J., and
   3. Chan, D.

   (2022b). Improving Efficiency in Medical Diagnosis. JAMA, 327(22):2189–2190.

   OpenUrl
7. 1. Bardsley, M.,
   2. Blunt, I.,
   3. Davies, S., and
   4. Dixon, J.

   (2013). Is secondary preventive care improving? Observational study of 10-year trends in emergency admissions for conditions amenable to ambulatory care. BMJ open, 3(1).
8. 1. Belloni, A.,
   2. Chernozhukov, V., et al.

   (2013). Least squares after model selection in highdimensional sparse models. Bernoulli, 19(2):521–547.

   OpenUrl
9. 1. Bennett, D.,
   2. Hung, C.-L., and
   3. Lauderdale, T.-L.

   (2015). Health care competition and antibiotic use in Taiwan. Journal of Industrial Economics, 63(2):371–393.

   OpenUrlCrossRef
10. 1. Chan, D. C.

    (2021). Influence and Information in Team Decisions: Evidence from Medical Residency. American Economic Journal: Economic Policy, 13(1):106–137.

    OpenUrl
11. 1. Chan, D. C.,
    2. Gentzkow, M., and
    3. Yu, C.

    (2022). Selection with variation in diagnostic skill: Evidence from radiologists. Quarterly Journal of Economics, 137(2):729–783.

    OpenUrl
12. 1. Chandra, A. and
    2. Staiger, D. O.

    (2007). Productivity spillovers in health care: Evidence from the treatment of heart attacks. Journal of Political Economy, 115(1):103–140.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Coenen, S.,
    2. Ferech, M.,
    3. Haaijer-Ruskamp, F. M.,
    4. Butler, C. C.,
    5. Vander Stichele, R. H.,
    6. Verheij, T. J.,
    7. Monnet, D. L.,
    8. Little, P., and
    9. Goossens, H.

    (2007). European Surveillance of Antimicrobial Consumption (ESAC): Quality indicators for outpatient antibiotic use in Europe. BMJ Quality & Safety, 16(6):440–445.

    OpenUrlAbstract/FREE Full Text
14. 1. Costelloe, C.,
    2. Metcalfe, C.,
    3. Lovering, A.,
    4. Mant, D., and
    5. Hay, A. D.

    (2010). Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: Systematic review and meta-analysis. BMJ, 340:c2096.

    OpenUrlAbstract/FREE Full Text
15. 1. Currie, J.

    (2022). Rules vs. Discretion: Treatment of Mental Illness in U.S. Adolescents. Journal of Political Economy (forthcoming).
16. 1. Currie, J.,
    2. Lin, W., and
    3. Meng, J.

    (2014). Addressing antibiotic abuse in China: An experimental audit study. Journal of Development Economics, 110:39–51.

    OpenUrlCrossRefPubMed
17. 1. Currie, J.,
    2. MacLeod, W. B., and
    3. Van Parys, J.

    (2016). Provider practice style and patient health outcomes: The case of heart attacks. Journal of Health Economics, 47:64–80.

    OpenUrlCrossRefPubMed
18. 1. Currie, J. M. and
    2. MacLeod, W. B.

    (2020). Understanding Doctor Decision Making: The Case of Depression Treatment. Econometrica, 88(3):847–878.

    OpenUrl
19. 1. Cutler, D.,
    2. Skinner, J. S.,
    3. Stern, A. D., and
    4. Wennberg, D.

    (2019). Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health Care Spending. American Economic Journal: Economic Policy, 11(1):192–221.

    OpenUrl
20. 1. Doyle, J. J.,
    2. Ewer, S. M., and
    3. Wagner, T. H.

    (2010). Returns to physician human capital: Evidence from patients randomized to physician teams. Journal of Health Economics, 29(6):866–882.

    OpenUrlPubMed
21. ECDC, EFSA Panel on Biological Hazards (BIOHAZ) and EMA Committee for Medicinal Products for Veterinary Use (CVMP) (2017). ECDC, EFSA and EMA Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals. EFSA journal, 15(10):e05017.

    OpenUrl
22. 1. Ellegård, L. M.,
    2. Dietrichson, J., and
    3. Anell, A.

    (2018). Can pay-for-performance to primary care providers stimulate appropriate use of antibiotics? Health Economics, 27(1):e39–e54.

    OpenUrl
23. 1. Epstein, A. J. and
    2. Nicholson, S.

    (2009). The formation and evolution of physician treatment styles: An application to cesarean sections. Journal of Health Economics, 28(6):1126–1140.

    OpenUrlCrossRefPubMedWeb of Science
24. 1. Fadlon, I.,
    2. Lyngse, F. P., and
    3. Nielsen, T. H.

    (2020). Early career, life-cycle choices, and gender. Technical Report w28245, National Bureau of Economic Research, Cambridge, MA.
25. 1. Fadlon, I. and
    2. Van Parys, J.

    (2020). Primary care physician practice styles and patient care: Evidence from physician exits in medicare. Journal of Health Economics, 71:102304.

    OpenUrl
26. 1. Finkelstein, A.,
    2. Gentzkow, M.,
    3. Li, D., and
    4. Williams, H.

    (2021). What Drives Prescription Opioid Abuse? Technical report, Working Paper.
27. 1. Finkelstein, A.,
    2. Gentzkow, M., and
    3. Williams, H.

    (2016). Sources of geographic variation in health care: Evidence from patient migration. Quarterly Journal of Economics, 131(4):1681–1726.

    OpenUrlCrossRefPubMed
28. 1. Fleming-Dutra, K. E.,
    2. Hersh, A. L.,
    3. Shapiro, D. J.,
    4. Bartoces, M.,
    5. Enns, E. A.,
    6. File, T. M.,
    7. Finkelstein, J. A.,
    8. Gerber, J. S.,
    9. Hyun, D. Y.,
    10. Linder, J. A., et al.

    (2016). Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011. JAMA, 315(17):1864–1873.

    OpenUrlCrossRefPubMed
29. 1. Godøy, A. and
    2. Huitfeldt, I.

    (2020). Regional variation in health care utilization and mortality. Journal of Health Economics, 71:102254.

    OpenUrl
30. 1. Goodman-Bacon, A.

    (2021). Difference-in-differences with variation in treatment timing. Journal of Econometrics, 225(2):254–277.

    OpenUrlCrossRef
31. 1. Gruber, J.,
    2. Handel, B. R.,
    3. Kina, S. H., and
    4. Kolstad, J. T.

    (2020). Managing Intelligence: Skilled Experts and AI in Markets for Complex Products. NBER Working Paper No. 27038, National Bureau of Economic Research.
32. 1. Hallsworth, M.,
    2. Chadborn, T.,
    3. Sallis, A.,
    4. Sanders, M.,
    5. Berry, D.,
    6. Greaves, F.,
    7. Clements, L., and
    8. Davies, S. C.

    (2016). Provision of social norm feedback to high prescribers of antibiotics in general practice: A pragmatic national randomised controlled trial. The Lancet, 387(10029):1743–1752.

    OpenUrl
33. 1. Hammerum, A. M.,
    2. Heuer, O. E.,
    3. Emborg, H.-D.,
    4. Bagger-Skjøt, L.,
    5. Jensen, V. F.,
    6. Rogues, A.-M.,
    7. Skov, R. L.,
    8. Agersø, Y.,
    9. Brandt, C. T.,
    10. Seyfarth, A. M.,
    11. Muller, A.,
    12. Hovgaard, K.,
    13. Ajufo, J.,
    14. Bager, F.,
    15. Aarestrup, F. M.,
    16. Frimodt-Møller, N.,
    17. Wegener, H. C., and
    18. Monnet, D. L.

    (2007). Danish Integrated Antimicrobial Resistance Monitoring and Research Program. Emerging Infectious Diseases, 13(11):1633–1639.

    OpenUrlCrossRef
34. 1. Hull, P.

    (2018). Estimating Treatment Effects in Mover Designs. Technical report, Working Paper.
35. 1. Kristiansen, I. L. and
    2. Sheng, S. Y.

    (2022). Doctor Who? The Effect of Physician-Patient Match on The SES-Health Gradient. CEBI Working Paper No. 05/22.
36. 1. Laxminarayan, R.

    (2022). The overlooked pandemic of antimicrobial resistance. The Lancet, 399(10325):P606–607.

    OpenUrl
37. 1. Laxminarayan, R.,
    2. Brown, G. M., et al.

    (2001). Economics of antibiotic resistance: A theory of optimal use. Journal of Environmental Economics and Management, 42(2):183–206.

    OpenUrlCrossRefWeb of Science
38. 1. Manski, C. F.

    (2018). Reasonable patient care under uncertainty. Health Economics, 27(10):1397–1421.

    OpenUrl
39. 1. Meeker, D.,
    2. Linder, J. A.,
    3. Fox, C. R.,
    4. Friedberg, M. W.,
    5. Persell, S. D.,
    6. Goldstein, N. J.,
    7. Knight, T. K.,
    8. Hay, J. W., and
    9. Doctor, J. N.

    (2016). Effect of behavioral interventions on inappropriate antibiotic prescribing among primary care practices: A randomized clinical trial. JAMA, 315(6):562–570.

    OpenUrlCrossRefPubMed
40. 1. Molitor, D.

    (2018). The evolution of physician practice styles: Evidence from cardiologist migration. American Economic Journal: Economic Policy, 10(1):326–56.

    OpenUrl
41. 1. Pulcini, C.,
    2. Wencker, F.,
    3. Frimodt-Møller, N.,
    4. Kern, W. V.,
    5. Nathwani, D.,
    6. Rodríguez-Baño, J.,
    7. Simonsen, G. S.,
    8. Vlahović-Palčevski, V.,
    9. Gyssens, I. C.,
    10. Gyssens, I. C.,
    11. Jacobs, F.,
    12. Peetermans, W.,
    13. Francetić, I.,
    14. Vlahović-Palčevski, V.,
    15. Frimodt-Mǿller, N.,
    16. Høiby, N.,
    17. Kilian, M.,
    18. Ader, F.,
    19. Cazorla, C.,
    20. Etienne, M.,
    21. Pulcini, C.,
    22. Fätkenheuer, G.,
    23. Kern, W. V.,
    24. Pletz, M. W.,
    25. Salzberger, B.,
    26. Cacopardo, B.,
    27. Mikulska, M.,
    28. Mussini, C.,
    29. Orlando, G.,
    30. Stefani, S.,
    31. Gyssens, I. C.,
    32. Lowe, S. H.,
    33. Nouwen, J. L.,
    34. Afset, J. E.,
    35. Bergh, K.,
    36. Müller, F.,
    37. Simonsen, G. S.,
    38. Carevic, B.,
    39. Horvat, O.,
    40. Jankovic, S.,
    41. Beović, B.,
    42. Gorisek, J. R.,
    43. Canton, R.,
    44. Fariñas, M. C.,
    45. Gudiol, F.,
    46. Paño Pardo, J. R.,
    47. Rodríguez Baño, J.,
    48. Harbarth, S.,
    49. Zanetti, G.,
    50. Barlow, G.,
    51. Brown, N.,
    52. Healy, B., and
    53. Nathwani, D.

    (2015). European survey on principles of prudent antibiotic prescribing teaching in undergraduate students. Clinical Microbiology and Infection, 21(4):354–361.

    OpenUrlPubMed
42. 1. Ribers, M. A. and
    2. Ullrich, H.

    (2023a). Machine learning and physician prescribing: A path to reduced antibiotic use. Berlin School of Economics Discussion Paper Nr. 19.
43. 1. Ribers, M. A. and
    2. Ullrich, H.

    (2023b). Machine predictions and human decisions with variation in payoffs and skill: The case of antibiotic prescribing. Berlin School of Economics Discussion Paper Nr. 27.
44. 1. Salm, M. and
    2. Wübker, A.

    (2020). Sources of regional variation in healthcare utilization in Germany. Journal of Health Economics, 69:102271.

    OpenUrl
45. 1. Schnell, M. and
    2. Currie, J.

    (2018). Addressing the Opioid Epidemic: Is There a Role for Physician Education? American Journal of Health Economics, 4(3):383–410.

    OpenUrl
46. 1. Simeonova, E.,
    2. Skipper, N., and
    3. Thingholm, P. R.

    (2022). Physician Health Management Skills and Patient Outcomes. Journal of Human Resources, pages 0420–10833R1.
47. 1. Simonsen, M.,
    2. Skipper, L.,
    3. Skipper, N., and
    4. Thingholm, P. R.

    (2021). Discontinuity in care: Practice closures among primary care providers and patient health care utilization. Journal of Health Economics, 80:102551.

    OpenUrl
48. 1. Sun, L. and
    2. Abraham, S.

    (2021). Estimating dynamic treatment effects in event studies with heterogeneous treatment effects. Journal of Econometrics, 225(2):175–199.

    OpenUrlCrossRef
49. World Bank (2017). Drug-resistant infections: A threat to our economic future.
50. World Health Organization Regional Office for Europe (2016). Assessing health services delivery performance with hospitalizations for ambulatory care sensitive conditions. Technical report.